AJP - Heart Journal of Neurophysiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (May 29, 2003). doi:10.1152/ajpheart.00260.2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
285/4/H1370    most recent
00260.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (15)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LU, L.
Right arrow Articles by ZHU, Y.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LU, L.
Right arrow Articles by ZHU, Y.-C.
Submitted on March 20, 2003
Accepted on May 23, 2003

Chronic all-trans retinoic acid treatment prevents medial thickening of intramyocardial- and intrarenal arteries in spontanously hypertensive rats

LEI LU1, TAI YAO1, YI-ZHUN ZHU2, GUO-YING HUANG3, YIN-XIANG CAO1, and YI-CHUN ZHU1*

1 Department of Physiology and Pathophysiology, Fudan University Shanghai Medical College, Shanghai, China
2 Department of Pharmacology, National University of Singapore, Singapore
3 The Children's Hospital, Fudan University Shanghai Medical College, Shanghai, China

* To whom correspondence should be addressed. E-mail: yczhu{at}shmu.edu.cn.

There are in vitro data linking all-trans retinoic acid (atRA) with inhibition of hypertrophy and hyperplasia in cardiomyocytes, vascular smooth muscle cells and fibroblast. In the present study, we testified the hypothesis that chronic treatment with atRA may blunt the process of myocardial remodeling in spontanously hypertensive rats (SHR). Four-week-old male SHR were treated with atRA (5mg. kg-1. d-1 or 10mg . kg-1. d-1) given daily for 3 months by gavage, age- and sex-matched Wistar-Kyoto (WKY)rats and placebo-treated SHRs were served as control. At the end of the treatment period, cardiac geometry and function was assessed by Doppler-echocardiography. Histological examination and radioimmunoassay were performed to evaluate medial thickening of intramyocardial- and renal arteries, perivascular and interstitial collagen content, and atrial natriuretic peptide (ANP) and insulin-like growth factor-1 (IGF-1) in the heart, respectively. The novel finding of the present study is that atRA prevented the hypertrophy of intramyocardial- and intrarenal arteries and ventricular fibrosis. However, atRA treatment did not lower blood pressure, nor the left ventricular weight (LVW) and left ventricular weight to body weight ratio (LVW/BW) in SHRs. atRA did not change cardiac geometry and function as assessed by Doppler-echocardiography. atRA showed no influence on either the ANP or the IGF-1 levels. In conclusion, the present study suggests that chronic atRA treatment prevents medial thickening of intramyocardial- and intrarenal arteries and ventricular fibrosis during the development of hypertension. Left ventricular hypertrophy, cardiac geometry and function are not changed by atRA treatment.




This article has been cited by other articles:


Home page
J CARDIOVASC PHARMACOL THERHome page
A. Baraka, M. Mikhail, A. Guemei, and S. El Ghotny
Effect of Targeting Mitogen-Activated Protein Kinase on Cardiac Remodeling in Rats
Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2009; 14(4): 339 - 346.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
B. Zheng, M. Han, M. Bernier, X.-h. Zhang, F. Meng, S.-b. Miao, M. He, X.-m. Zhao, and J.-k. Wen
Kruppel-like Factor 4 Inhibits Proliferation by Platelet-derived Growth Factor Receptor {beta}-mediated, Not by Retinoic Acid Receptor {alpha}-mediated, Phosphatidylinositol 3-Kinase and ERK Signaling in Vascular Smooth Muscle Cells
J. Biol. Chem., August 21, 2009; 284(34): 22773 - 22785.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. Choudhary, A. Palm-Leis, R. C. Scott III, R. S. Guleria, E. Rachut, K. M. Baker, and J. Pan
All-trans retinoic acid prevents development of cardiac remodeling in aortic banded rats by inhibiting the renin-angiotensin system
Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H633 - H644.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. S. Maier
Vitamin A for the heart: progress for cardiac hypertrophy regression?
Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H588 - H589.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y.-X. Shi, Y. Chen, Y.-Z. Zhu, G.-Y. Huang, P. K. Moore, S.-H. Huang, T. Yao, and Y.-C. Zhu
Chronic sodium hydrosulfide treatment decreases medial thickening of intramyocardial coronary arterioles, interstitial fibrosis, and ROS production in spontaneously hypertensive rats
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2093 - H2100.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. A. R. Paiva, L. S. Matsubara, B. B. Matsubara, M. F. Minicucci, P. S. Azevedo, A. O. Campana, and L. A. M. Zornoff
Retinoic Acid Supplementation Attenuates Ventricular Remodeling after Myocardial Infarction in Rats
J. Nutr., October 1, 2005; 135(10): 2326 - 2328.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J.-C. Zhong, D.-Y. Huang, Y.-M. Yang, Y.-F. Li, G.-F. Liu, X.-H. Song, and K. Du
Upregulation of Angiotensin-Converting Enzyme 2 by All-trans Retinoic Acid in Spontaneously Hypertensive Rats
Hypertension, December 1, 2004; 44(6): 907 - 912.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1976 by the American Physiological Society.